Filed: 11/13/2025ACC: 0000950142-25-002960
📋 What this filing means
GENERAL ATLANTIC, L.P. filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $3.33B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$3.33B
Total AUM (reported)
188.27M
Total Shares
Allocation by class
COM$1.32B39.5%
CLASS A COM$718.57M21.6%
CL A$532.40M16.0%
COM SHS CL A$387.44M11.6%
SPONSERED ADS$234.78M7.0%
ORD SHS$106.47M3.2%
SHS CL A$24.92M0.7%
Portfolio Concentration
Top 3$1.57B47.1%
4–10$1.61B48.5%
11–25$146.57M4.4%
Top 3 weight
47.1%
Top 10 weight
95.6%
Voting Authority Distribution
Total shares with voting rights: 188.27M
Sole
Full voting authority
188.27M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
DLOCAL
SOLEShares46.66M
TypeSH
Market value$666.26M
20.00%
Sole
46.66M
Shared
0.00
None
0.00
XP, INC
SOLEShares25.52M
TypeSH
Market value$479.48M
14.40%
Sole
25.52M
Shared
0.00
None
0.00
ALIGNMENT HEALTHCARE
SOLEShares24.29M
TypeSH
Market value$423.81M
12.72%
Sole
24.29M
Shared
0.00
None
0.00
CHIME
SOLEShares19.21M
TypeSH
Market value$387.44M
11.63%
Sole
19.21M
Shared
0.00
None
0.00
ALKAMI
SOLEShares11.99M
TypeSH
Market value$297.87M
8.94%
Sole
11.99M
Shared
0.00
None
0.00
AKERO THERAPEUTICS
SOLEShares5.73M
TypeSH
Market value$272.25M
8.17%
Sole
5.73M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS
SOLEShares9.68M
TypeSH
Market value$234.78M
7.05%
Sole
9.68M
Shared
0.00
None
0.00
PHARVARIS
SOLEShares8.03M
TypeSH
Market value$200.38M
6.02%
Sole
8.03M
Shared
0.00
None
0.00
REVOLUTION MEDICINES
SOLEShares2.47M
TypeSH
Market value$115.56M
3.47%
Sole
2.47M
Shared
0.00
None
0.00
WEBULL
SOLEShares7.20M
TypeSH
Market value$106.47M
3.20%
Sole
7.20M
Shared
0.00
None
0.00
ROYALTY PHARMA
SOLEShares1.50M
TypeSH
Market value$52.92M
1.59%
Sole
1.50M
Shared
0.00
None
0.00
EUROPEAN WAX CENTER
SOLEShares13.11M
TypeSH
Market value$52.31M
1.57%
Sole
13.11M
Shared
0.00
None
0.00
RISKIFIED
SOLEShares5.32M
TypeSH
Market value$24.92M
0.75%
Sole
5.32M
Shared
0.00
None
0.00
ADAGENE
SOLEShares3.78M
TypeSH
Market value$7.53M
0.23%
Sole
3.78M
Shared
0.00
None
0.00
ALUMIS
SOLEShares1.30M
TypeSH
Market value$5.18M
0.16%
Sole
1.30M
Shared
0.00
None
0.00
GROVE COLLABORATIVE
SOLEShares2.47M
TypeSH
Market value$3.71M
0.11%
Sole
2.47M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DLOCALSOLE | CLASS A COM | 46.66M | SH | $666.26M 20.00% | 46.66M | 0.00 | 0.00 |
XP, INCSOLE | CL A | 25.52M | SH | $479.48M 14.40% | 25.52M | 0.00 | 0.00 |
ALIGNMENT HEALTHCARESOLE | COM | 24.29M | SH | $423.81M 12.72% | 24.29M | 0.00 | 0.00 |
CHIMESOLE | COM SHS CL A | 19.21M | SH | $387.44M 11.63% | 19.21M | 0.00 | 0.00 |
ALKAMISOLE | COM | 11.99M | SH | $297.87M 8.94% | 11.99M | 0.00 | 0.00 |
AKERO THERAPEUTICSSOLE | COM | 5.73M | SH | $272.25M 8.17% | 5.73M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALSSOLE | SPONSERED ADS | 9.68M | SH | $234.78M 7.05% | 9.68M | 0.00 | 0.00 |
PHARVARISSOLE | COM | 8.03M | SH | $200.38M 6.02% | 8.03M | 0.00 | 0.00 |
REVOLUTION MEDICINESSOLE | COM | 2.47M | SH | $115.56M 3.47% | 2.47M | 0.00 | 0.00 |
WEBULLSOLE | ORD SHS | 7.20M | SH | $106.47M 3.20% | 7.20M | 0.00 | 0.00 |
ROYALTY PHARMASOLE | CL A | 1.50M | SH | $52.92M 1.59% | 1.50M | 0.00 | 0.00 |
EUROPEAN WAX CENTERSOLE | CLASS A COM | 13.11M | SH | $52.31M 1.57% | 13.11M | 0.00 | 0.00 |
RISKIFIEDSOLE | SHS CL A | 5.32M | SH | $24.92M 0.75% | 5.32M | 0.00 | 0.00 |
ADAGENESOLE | ADS | 3.78M | SH | $7.53M 0.23% | 3.78M | 0.00 | 0.00 |
ALUMISSOLE | COM | 1.30M | SH | $5.18M 0.16% | 1.30M | 0.00 | 0.00 |
GROVE COLLABORATIVESOLE | COM CL A | 2.47M | SH | $3.71M 0.11% | 2.47M | 0.00 | 0.00 |